Yes, the same life expectancy as HIV-negative people, but far fewer years in good health
Unique transgender vulnerabilities require tailored and specific interventions
Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds
Experts shed light on coronavirus response and its implications for people with HIV
SEARCH study finds universal 'test and treat' reduces infant HIV
Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity
HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women
Younger people with HIV lose lung function faster
